Axon Enterprise, Inc (NASDAQ:AXON) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $699.55.

A number of analysts have issued reports on the company. Barclays raised their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Needham & Company LLC raised their price target on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. The Goldman Sachs Group raised their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, Bank of America raised their price target on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th.

Insider Activity

In related news, President Joshua Isner sold 9,000 shares of the firm's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the sale, the president now directly owns 308,714 shares in the company, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Jennifer H. Mak sold 75 shares of the firm's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the sale, the chief accounting officer now owns 15,240 shares in the company, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock valued at $30,500,428 in the last three months. Corporate insiders own 5.70% of the company's stock.

Institutional Investors Weigh In On Axon Enterprise

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Fourth Dimension Wealth LLC bought a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $30,000. TCTC Holdings LLC increased its holdings in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after acquiring an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC increased its holdings in shares of Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC bought a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $32,000. Finally, Banque Transatlantique SA bought a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $31,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Trading Up 0.8%

Axon Enterprise stock opened at $783.24 on Tuesday. The stock has a market cap of $60.98 billion, a PE ratio of 189.19, a P/E/G ratio of 89.48 and a beta of 1.29. The stock has a 50-day moving average price of $696.32 and a 200 day moving average price of $625.93. Axon Enterprise has a 52 week low of $279.02 and a 52 week high of $806.64. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.15 EPS. Equities research analysts predict that Axon Enterprise will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.